As we come into the weekend, some personal reflection. Simply, I choose to be a "half glass full" guy, it's better for one's health, both physical & mental.
Regarding the capital situation, this needs to be balanced with an objective view of where we stand, but until proven otherwise I'm moving forward on the assumption that capital will get sorted and Conneqt Pulse will be launched before the end of the year. On balance, I think that this outcome is more likely than not.
To that end, there are tidbits of information coming through that says " business as usual " at CardieX. Craig & Niall have hopefully told the team ... " you worry about performance & job execution , let's us worry about capital, it's under control ".
Time will tell.
In the meantime, here are some of the tidbits.
Pop-Up booth at the Artery Conference.
Catherine Liao presenting on a discussion panel at MedTech Conference
Treadway Chllds revealing himself as having worked with CardieX since May ... this has only just appeared, maybe since the recent announcements. He joins us from DayTwo, and I assume came across on the behest of Josh, and has the runs on the board His role in CardieX is key GTM strategy for Conneqt Pulse - *Creation of a network of 1,000+ practitioners to adopt new CardieX blood pressure devices and practitioner dashboard
Have a good weekend all. Hopefully some good news next week, suspension lifted and trading recommences.
IMO DYOR
CDX Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
